{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:35:17Z","timestamp":1790508917294,"version":"4.1.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,7,26]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>A new molecular assay identifies conventional and leukemic nonnodal MCL with differing clinicobiological features. The integration of the novel assay with genetic alterations identifies subsets of MCL patients with different management and outcome.<\/jats:p>","DOI":"10.1182\/blood-2018-03-838136","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T18:20:19Z","timestamp":1526494819000},"page":"413-422","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":93,"title":["A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome"],"prefix":"10.1182","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2588-7413","authenticated-orcid":false,"given":"Guillem","family":"Clot","sequence":"first","affiliation":[{"name":"Institute for Biomedical Research August Pi i Sunyer, Barcelona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8401-579X","authenticated-orcid":false,"given":"Pedro","family":"Jares","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Research August Pi i Sunyer, Barcelona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain;"},{"name":"Hematopathology Unit-Laboratory of Pathology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0532-1204","authenticated-orcid":false,"given":"Eva","family":"Gin\u00e9","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Research August Pi i Sunyer, Barcelona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain;"},{"name":"Hematology Department, Hospital Clinic of Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4041-0974","authenticated-orcid":false,"given":"Alba","family":"Navarro","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Research August Pi i Sunyer, Barcelona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Royo","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Research August Pi i Sunyer, Barcelona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Pinyol","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Research August Pi i Sunyer, Barcelona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0289-5915","authenticated-orcid":false,"given":"David","family":"Mart\u00edn-Garcia","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Research August Pi i Sunyer, Barcelona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3998-8784","authenticated-orcid":false,"given":"Santiago","family":"Demajo","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Research August Pi i Sunyer, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Espinet","sequence":"additional","affiliation":[{"name":"Pathology Department and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4652-4825","authenticated-orcid":false,"given":"Antonio","family":"Salar","sequence":"additional","affiliation":[{"name":"Hematology Department, IMIM-Hospital del Mar, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3381-9472","authenticated-orcid":false,"given":"Ana","family":"Ferrer","sequence":"additional","affiliation":[{"name":"Hematology Department, IMIM-Hospital del Mar, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Munta\u00f1ola","sequence":"additional","affiliation":[{"name":"Servei d'Hematologia, Hospital M\u00fatua de Terrassa, Terrassa, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Aymerich","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain;"},{"name":"Hematopathology Unit-Laboratory of Pathology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilka","family":"Rauert-Wunderlich","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University of W\u00fcrzburg, W\u00fcrzburg, Germany;"},{"name":"Comprehensive Cancer Center Mainfranken, W\u00fcrzburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4632-0301","authenticated-orcid":false,"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[{"name":"Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1361-7531","authenticated-orcid":false,"given":"Joseph M.","family":"Connors","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy D.","family":"Gascoyne","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5023-0689","authenticated-orcid":false,"given":"Jan","family":"Delabie","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toronto General Hospital, Toronto, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8588-8381","authenticated-orcid":false,"given":"Armando","family":"L\u00f3pez-Guillermo","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Research August Pi i Sunyer, Barcelona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain;"},{"name":"Hematology Department, Hospital Clinic of Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Robert-Bosch-Krankenhaus and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W.","family":"Wright","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center Mainfranken, W\u00fcrzburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis M.","family":"Staudt","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center Mainfranken, W\u00fcrzburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University of W\u00fcrzburg, W\u00fcrzburg, Germany;"},{"name":"Comprehensive Cancer Center Mainfranken, W\u00fcrzburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Scott","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Rimsza","sequence":"additional","affiliation":[{"name":"Department of Pathology, Mayo Clinic, Scottsdale, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7192-2385","authenticated-orcid":false,"given":"S\u00edlvia","family":"Be\u00e0","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Research August Pi i Sunyer, Barcelona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9850-9793","authenticated-orcid":false,"given":"El\u00edas","family":"Campo","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Research August Pi i Sunyer, Barcelona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain;"},{"name":"Hematopathology Unit-Laboratory of Pathology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2019111812582354000_B1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1182\/blood-2014-05-521898","article-title":"Mantle cell lymphoma: evolving management strategies","volume":"125","author":"Campo","year":"2015","journal-title":"Blood"},{"issue":"4","key":"2019111812582354000_B2","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma","volume":"70","author":"Fern\u00e0ndez","year":"2010","journal-title":"Cancer Res"},{"issue":"4","key":"2019111812582354000_B3","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1158\/1078-0432.CCR-13-1077","article-title":"Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry","volume":"20","author":"Espinet","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"12","key":"2019111812582354000_B4","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1182\/blood-2002-06-1864","article-title":"A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease","volume":"101","author":"Orchard","year":"2003","journal-title":"Blood"},{"issue":"8","key":"2019111812582354000_B5","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1200\/JCO.2008.19.6121","article-title":"Outcome of deferred initial therapy in mantle-cell lymphoma","volume":"27","author":"Martin","year":"2009","journal-title":"J Clin Oncol"},{"issue":"20","key":"2019111812582354000_B6","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"8","key":"2019111812582354000_B7","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/leu.2012.72","article-title":"Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease","volume":"26","author":"Royo","year":"2012","journal-title":"Leukemia"},{"issue":"20","key":"2019111812582354000_B8","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1158\/0008-5472.CAN-12-1615","article-title":"Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features","volume":"72","author":"Navarro","year":"2012","journal-title":"Cancer Res"},{"issue":"5","key":"2019111812582354000_B9","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.ccell.2016.09.014","article-title":"Decoding the DNA methylome of mantle cell lymphoma in the light of the entire B cell lineage","volume":"30","author":"Queir\u00f3s","year":"2016","journal-title":"Cancer Cell"},{"issue":"8","key":"2019111812582354000_B10","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3324\/haematol.2010.036277","article-title":"Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis","volume":"96","author":"Ondrejka","year":"2011","journal-title":"Haematologica"},{"issue":"2","key":"2019111812582354000_B11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/modpathol.2017.135","article-title":"CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course","volume":"31","author":"Hu","year":"2018","journal-title":"Mod Pathol"},{"issue":"21","key":"2019111812582354000_B12","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1182\/blood-2017-10-764373","article-title":"Chronic lymphocytic leukemia and mantle cell lymphoma: Crossroads of genetic and microenvironment interactions","volume":"131","author":"Puente","year":"2018","journal-title":"Blood"},{"issue":"1","key":"2019111812582354000_B13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/PAS.0b013e3182a43996","article-title":"Assessment of SOX11 expression in routine lymphoma tissue sections: characterization of new monoclonal antibodies for diagnosis of mantle cell lymphoma","volume":"38","author":"Soldini","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"18","key":"2019111812582354000_B14","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1182\/blood-2011-12-400580","article-title":"Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma","volume":"119","author":"Nygren","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2019111812582354000_B15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/bjh.12854","article-title":"SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma--a Nordic Lymphoma Group study","volume":"166","author":"Nordstr\u00f6m","year":"2014","journal-title":"Br J Haematol"},{"issue":"6","key":"2019111812582354000_B16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/14737140.2017.1328280","article-title":"Novel agents in mantle cell lymphoma","volume":"17","author":"Tucker","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"issue":"4","key":"2019111812582354000_B17","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3109\/10428194.2014.940584","article-title":"Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th Annual Conference of the European Mantle Cell Lymphoma Network","volume":"56","author":"Dreyling","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"2019111812582354000_B18","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3324\/haematol.2015.127472","article-title":"Personalized medicine in lymphoma: is it worthwhile? The mantle cell lymphoma experience","volume":"100","author":"Dreyling","year":"2015","journal-title":"Haematologica"},{"issue":"3","key":"2019111812582354000_B19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/j.seminhematol.2011.03.010","article-title":"Is there a role for \u201cwatch and wait\u201d in patients with mantle cell lymphoma?","volume":"48","author":"Martin","year":"2011","journal-title":"Semin Hematol"},{"issue":"10","key":"2019111812582354000_B20","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1093\/annonc\/mdx333","article-title":"Observation as the initial management strategy in patients with mantle cell lymphoma","volume":"28","author":"Abrisqueta","year":"2017","journal-title":"Ann Oncol"},{"issue":"32","key":"2019111812582354000_B21","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1200\/JCO.2009.23.9731","article-title":"Time to treatment does not influence overall survival in newly diagnosed mantle-cell lymphoma","volume":"27","author":"Eve","year":"2009","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019111812582354000_B22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","article-title":"The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma","volume":"3","author":"Rosenwald","year":"2003","journal-title":"Cancer Cell"},{"issue":"12","key":"2019111812582354000_B23","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1200\/JCO.2015.63.8387","article-title":"Prognostic value of Ki-67 index, cytology, and growth pattern in mantle-cell lymphoma: results from randomized trials of the European Mantle Cell Lymphoma Network","volume":"34","author":"Hoster","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019111812582354000_B24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12308-009-0036-x","article-title":"Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network","volume":"2","author":"Klapper","year":"2009","journal-title":"J Hematop"},{"issue":"15","key":"2019111812582354000_B25","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1200\/JCO.2016.70.7901","article-title":"New molecular assay for the proliferation signature in mantle cell lymphoma applicable to formalin-fixed paraffin-embedded biopsies","volume":"35","author":"Scott","year":"2017","journal-title":"J Clin Oncol"},{"issue":"9","key":"2019111812582354000_B26","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.3324\/haematol.2016.160374","article-title":"Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifier","volume":"102","author":"Navarro","year":"2017","journal-title":"Haematologica"},{"issue":"1-3","key":"2019111812582354000_B27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12026-015-8688-3","article-title":"A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytes","volume":"63","author":"McCarthy","year":"2015","journal-title":"Immunol Res"},{"issue":"2","key":"2019111812582354000_B28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/biostatistics\/kxp059","article-title":"Frozen robust multiarray analysis (fRMA)","volume":"11","author":"McCall","year":"2010","journal-title":"Biostatistics"},{"issue":"45","key":"2019111812582354000_B29","doi-asserted-by":"crossref","first-page":"18250","DOI":"10.1073\/pnas.1314608110","article-title":"Landscape of somatic mutations and clonal evolution in mantle cell lymphoma","volume":"110","author":"Be\u00e0","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019111812582354000_B30","doi-asserted-by":"crossref","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments","volume-title":"Stat Appl Genet Mol Biol","author":"Smyth","year":"2004"},{"issue":"3","key":"2019111812582354000_B31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/biostatistics\/kxq069","article-title":"Probabilistic classifiers with high-dimensional data","volume":"12","author":"Kim","year":"2011","journal-title":"Biostatistics"},{"issue":"1","key":"2019111812582354000_B32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Softw"},{"issue":"4","key":"2019111812582354000_B33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"issue":"12","key":"2019111812582354000_B34","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1002\/cncr.22715","article-title":"Leukemic involvement is a common feature in mantle cell lymphoma","volume":"109","author":"Ferrer","year":"2007","journal-title":"Cancer"},{"issue":"1","key":"2019111812582354000_B35","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1182\/blood-2015-11-681460","article-title":"Pathogenic role of B-cell receptor signaling and canonical NF-\u03baB activation in mantle cell lymphoma","volume":"128","author":"Saba","year":"2016","journal-title":"Blood"},{"issue":"12","key":"2019111812582354000_B36","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1038\/leu.2013.141","article-title":"SOX11 overexpression is a specific marker for mantle cell lymphoma and correlates with t(11;14) translocation, CCND1 expression and an adverse prognosis","volume":"27","author":"Meggendorfer","year":"2013","journal-title":"Leukemia"},{"issue":"10","key":"2019111812582354000_B37","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/onc.2014.44","article-title":"High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma","volume":"34","author":"Kuo","year":"2015","journal-title":"Oncogene"},{"issue":"8","key":"2019111812582354000_B38","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1182\/blood.V87.8.3351.bloodjournal8783351","article-title":"p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas","volume":"87","author":"Hernandez","year":"1996","journal-title":"Blood"},{"issue":"10","key":"2019111812582354000_B39","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1182\/blood.V87.10.4302.bloodjournal87104302","article-title":"p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis","volume":"87","author":"Greiner","year":"1996","journal-title":"Blood"},{"issue":"1","key":"2019111812582354000_B40","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/blood.V89.1.272","article-title":"Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas","volume":"89","author":"Pinyol","year":"1997","journal-title":"Blood"},{"issue":"5","key":"2019111812582354000_B41","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/gcc.20754","article-title":"Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma","volume":"49","author":"Espinet","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"issue":"12","key":"2019111812582354000_B42","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1038\/leu.2011.162","article-title":"Impact of TP53 mutation and 17p deletion in mantle cell lymphoma","volume":"25","author":"Halld\u00f3rsd\u00f3ttir","year":"2011","journal-title":"Leukemia"},{"issue":"5","key":"2019111812582354000_B43","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1182\/blood-2015-02-628792","article-title":"High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma","volume":"126","author":"Delfau-Larue","year":"2015","journal-title":"Blood"},{"issue":"17","key":"2019111812582354000_B44","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2017-04-779736","article-title":"TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy","volume":"130","author":"Eskelund","year":"2017","journal-title":"Blood"},{"issue":"4","key":"2019111812582354000_B45","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1182\/blood-2017-07-797019","article-title":"Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network","volume":"131","author":"Aukema","year":"2018","journal-title":"Blood"},{"issue":"12","key":"2019111812582354000_B46","first-page":"4365","article-title":"Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants","volume":"93","author":"Be\u00e0","year":"1999","journal-title":"Blood"},{"issue":"1","key":"2019111812582354000_B47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/gcc.22123","article-title":"Complex karyotype in mantle cell lymphoma is a strong prognostic factor for the time to treatment and overall survival, independent of the MCL international prognostic index","volume":"53","author":"Sarkozy","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"issue":"11","key":"2019111812582354000_B48","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1182\/blood-2010-12-327858","article-title":"Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia","volume":"118","author":"Ouillette","year":"2011","journal-title":"Blood"},{"issue":"11","key":"2019111812582354000_B49","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.3324\/haematol.2014.108365","article-title":"Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption","volume":"99","author":"Delgado","year":"2014","journal-title":"Haematologica"},{"issue":"3","key":"2019111812582354000_B50","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1182\/blood-2016-01-691550","article-title":"Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy","volume":"128","author":"Herling","year":"2016","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/132\/4\/413\/1407452\/blood838136.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/132\/4\/413\/1407452\/blood838136.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T20:35:50Z","timestamp":1720298150000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/132\/4\/413\/103910\/A-gene-signature-that-distinguishes-conventional"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,26]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7,26]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2018-03-838136","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,26]]}}}